SYNLOGIC, INC. Payments to Acquire Debt Securities, Available-for-sale
SYNLOGIC, INC. (SYBX) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-03-12
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $0.00.
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $0.00.
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-06-30 was $0.00.
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $1.48M, a 94.71% decline from fiscal 2023.
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $27.93M, a 66.26% decline from fiscal 2022.
- SYNLOGIC, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $82.79M, a 50.68% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $1.48M 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $1.48M 10-Q · filed 2025-11-13 | $20.58M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.48M 10-Q · filed 2025-08-07 | $20.58M derived: sum of 3 quarters · filed 2025-08-07 | $29.41M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.48M 10-Q · filed 2025-05-08 | $20.58M derived: sum of 2 quarters · filed 2025-05-08 | $29.41M derived: sum of 3 quarters · filed 2025-05-08 | $29.41M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $19.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $27.93M derived: sum of 2 quarters · filed 2025-03-06 | $27.93M derived: sum of 3 quarters · filed 2025-03-06 | $27.93M 10-K · filed 2025-03-06 |
| 2023-09-30 | $8.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.83M derived: sum of 2 quarters · filed 2024-11-12 | $8.83M 10-Q · filed 2024-11-12 | $25.43M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $16.60M derived: sum of 3 quarters · filed 2024-08-08 | $41.67M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $16.60M derived: sum of 2 quarters · filed 2024-05-14 | $41.67M derived: sum of 3 quarters · filed 2024-05-14 | $70.67M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $16.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $41.67M derived: sum of 2 quarters · filed 2024-03-19 | $70.67M derived: sum of 3 quarters · filed 2024-03-19 | $82.79M 10-K · filed 2024-03-19 |
| 2022-09-30 | $25.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $54.07M derived: sum of 2 quarters · filed 2023-11-09 | $66.19M 10-Q · filed 2023-11-09 | $136.08M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $41.12M 10-Q · filed 2023-08-10 | $111.00M derived: sum of 3 quarters · filed 2023-08-10 | $134.97M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $12.12M 10-Q · filed 2023-05-11 | $82.01M derived: sum of 2 quarters · filed 2023-05-11 | $105.98M derived: sum of 3 quarters · filed 2023-05-11 | $152.90M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $69.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $93.86M derived: sum of 2 quarters · filed 2023-03-29 | $140.78M derived: sum of 3 quarters · filed 2023-03-29 | $167.87M 10-K · filed 2023-03-29 |
| 2021-09-30 | $23.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $70.89M derived: sum of 2 quarters · filed 2022-11-10 | $97.98M 10-Q · filed 2022-11-10 | $131.73M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $46.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $74.01M 10-Q · filed 2022-08-11 | $107.76M derived: sum of 3 quarters · filed 2022-08-11 | $124.74M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $27.09M 10-Q · filed 2022-05-12 | $60.84M derived: sum of 2 quarters · filed 2022-05-12 | $77.82M derived: sum of 3 quarters · filed 2022-05-12 | $99.30M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $33.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $50.73M derived: sum of 2 quarters · filed 2022-03-17 | $72.20M derived: sum of 3 quarters · filed 2022-03-17 | $86.47M 10-K · filed 2022-03-17 |
| 2020-09-30 | $16.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $38.46M derived: sum of 2 quarters · filed 2021-11-10 | $52.73M 10-Q · filed 2021-11-10 | $68.63M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $21.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $35.74M 10-Q · filed 2021-08-12 | $51.65M derived: sum of 3 quarters · filed 2021-08-12 | $72.53M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $14.27M 10-Q · filed 2021-05-13 | $30.17M derived: sum of 2 quarters · filed 2021-05-13 | $51.05M derived: sum of 3 quarters · filed 2021-05-13 | $120.34M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $36.78M derived: sum of 2 quarters · filed 2021-03-25 | $106.07M derived: sum of 3 quarters · filed 2021-03-25 | $145.42M 10-K · filed 2021-03-25 |
| 2019-09-30 | $20.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $90.17M derived: sum of 2 quarters · filed 2020-11-05 | $129.52M 10-Q · filed 2020-11-05 | $157.81M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $69.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $108.63M 10-Q · filed 2020-08-06 | $136.93M derived: sum of 3 quarters · filed 2020-08-06 | $166.54M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $39.35M 10-Q · filed 2020-05-08 | $67.64M derived: sum of 2 quarters · filed 2020-05-08 | $97.25M derived: sum of 3 quarters · filed 2020-05-08 | $137.27M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $28.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $57.91M derived: sum of 2 quarters · filed 2020-03-12 | $97.92M derived: sum of 3 quarters · filed 2020-03-12 | $172.89M 10-K · filed 2020-03-12 |
| 2018-09-30 | $29.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $69.63M derived: sum of 2 quarters · filed 2019-11-12 | $144.59M 10-Q · filed 2019-11-12 | $173.18M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $40.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $114.98M 10-Q · filed 2019-08-08 | $143.56M derived: sum of 3 quarters · filed 2019-08-08 | |
| 2018-03-31 | $74.96M 10-Q · filed 2019-05-09 | $103.55M derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $28.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $51.44M 10-K · filed 2019-03-12 | ||
| 2017-09-30 | $22.86M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |